Comparison

LEUKOCYTE ELASTASE

Item no. 20-321-175215
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Antibody
Clone 265-3K1
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-D078BD
Similar products 20-321-175215
Available
Genway ID:
GWB-D078BD
Clone:
265-3K1
Applications:
The monoclonal antibody 265-3K1 can be used for immuno assays and Western blotting. The monoclonal antibody 265-3K1 recognizes human leukocyte elastase. Leukocyte elastase. a major serine proteinase in man. is predominantly present in the azurophilic granules of neutrophils and monocytes. Elastase has a broad range of extracellular matrix substrates including elastin. proteoglycans. collagen and fibronectin. The action of elastase is controlled by serine proteinase inhibitors. Elastase. when released during inflammation. is rapidly bound by its two main inhibitors. alpha1-PI and alpha2-macroglobuline to form elastase-inhibitor complexes. In addition mucosa secretions may contain the locally secreted elastase inhibitors elafin/SKALP and SLPI. When secreted at sites of inflammation elastase can cause severe tissue damage. An important role has been suggested for human elastase in various inflammatory disorders. including pulmonary emphysema. sepsis. arthritis. nephritis and certain skin diseases. Elastase induces the production of IL-8 in human bronchial epithelial. a proces that occurs in part through TLR4.
Function:
Modifies the functions of natural killer cells monocytes and granulocytes. Inhibits C5a-dependent neutrophil enzyme release and chemotaxis.
Catalytic Activity:
Hydrolysis of proteins including elastin. Preferential cleavage: Val-|-Xaa & gt; Ala-|-Xaa.
Subunit:
Interacts with NOTCH2NL.
Tissue Specificity:
Bone marrow cells.
Disease:
Defects in ELA2 are a cause of cyclic haematopoiesis (CH) [MIM:162800]; also known as cyclic neutropenia. CH is an autosomal dominant disease in which blood-cell production from the bone marrow oscillates with 21-day periodicity. Circulating neutrophils vary between almost normal numbers and zero. During intervals of neutropenia affected individuals are at risk for opportunistic infection. Monocytes platelets lymphocytes and reticulocytes also cycle with the same frequency.
Disease:
Defects in ELA2 are the cause of autosomal dominant severe congenital neutropenia type 1 (SCN1) [MIM:202700]. Severe congenital neutropenia is a heterogeneous disorder of hematopoiesis characterized by a maturation arrest of granulopoiesis at the level of promyelocytes with peripheral blood absolute neutrophil counts below 0. 5 x 10(9)/l and early onset of severe bacterial infections.
Similarity:
Belongs to the peptidase S1 family. Elastase subfamily [view classification].
Similarity:
Contains 1 peptidase S1 domain [view classification].

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close